[Atrail fibrillation and heart failure: a complex relationship]

Marcello Costantini1, Anna Teresa Ranieri, Claudio Fachechi

  • 1U.O. di Cardiologia, Ospedale S. Caterina Novella, Azienda USL LE/1, Galatina (LE). marcellocostantini@virgilio.it

Giornale Italiano Di Cardiologia (2006)
|March 15, 2006
PubMed

Insights

Atrial fibrillation (AF) and heart failure (HF) frequently coexist, with each condition potentially causing the other through various mechanisms. Management strategies for AF in HF patients are evolving, considering new therapeutic approaches.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Context:

  • Atrial fibrillation (AF) and heart failure (HF) are highly prevalent and often comorbid cardiovascular conditions.
  • The bidirectional relationship between AF and HF presents complex challenges in patient management.
  • Understanding the intricate mechanisms linking these two diseases is crucial for therapeutic advancements.

Purpose:

  • To elucidate the complex interplay and shared etiological factors between atrial fibrillation and heart failure.
  • To explore the mechanisms by which AF can precipitate or worsen HF, and vice versa.
  • To discuss the implications for clinical management and emerging therapeutic strategies, including non-channel targeted therapies.

Summary:

  • AF and HF share common underlying causes and each can directly lead to the other.
  • AF contributes to HF through loss of synchrony, irregular/rapid ventricular response, and tachycardia-induced cardiomyopathy.
  • HF promotes AF via increased atrial mass, stretch, neuroendocrine changes, and fibrosis, with prevalence increasing with HF severity.
  • AF's impact on HF prognosis is variable, particularly in advanced stages, influencing management decisions.
  • Rhythm vs. rate control trials and novel therapies like non-channel target therapy offer insights for managing AF in HF patients.

Impact:

  • Provides a comprehensive overview of the AF-HF relationship, aiding clinicians in diagnosis and treatment.
  • Highlights the importance of considering the bidirectional nature of AF and HF in clinical practice.
  • Suggests potential avenues for future research and therapeutic development in managing comorbid AF and HF.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...